Kilitch Drugs (India) Limited Share Price and Company Fundamentals
Last traded: Today at 6:58 AM
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of liquid ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrup, gripe water, and oral powder and liquid in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.
Key Metrics
PE ratio
37.02
PB ratio
3.28
Dividend yield
0.00%
Beta
0.30
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Drug Manufacturers—Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 153 |
| Website | https://www.kilitch.com |
| Mailing address | 37/39, Ujagar Industrial Estate Waman Tukaram Patil Marg Deonar Mumbai 400088 India |
| Phone / Fax | 91 22 6121 4100 / 91 22 6703 1658 |
Dividends
Dividend yield
0.00%
Dividend amount
₹0.00
Payout ratio
0.00%
Kilitch Drugs (India) Limited paid ₹0.00 dividend and the ex-dividend date was 20 Sept 2019.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.KILITCH dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
KILITCH's forward dividend amount is ₹ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of May 2024, following are the company executives and directors listed on Kilitch Drugs (India) Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Mukund Prataprai Mehta | Executive Chairman & MD | 70 | 6M |
| Mr. Bhavin Mukund Mehta B.Pharm. | Whole-time Director | 47 | 8.4M |
| Ms. Mira Bhavin Mehta | Whole Time Director | 45 | 2.4M |
| Mr. Sunil Sureshji Jain | Chief Financial Officer | 40 | 1.5M |
| Ms. Pushpa Nyoupane | Company Secretary & Compliance Officer |
Profitability and management effectiveness
Profit margin
9.40%
Operating margin
4.61%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Kilitch Drugs (India) Limited is and its enterprise value is .
The KILITCH's stocks Beta value is 0.30 making it 70% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Kilitch Drugs (India) Limited (NSE:KILITCH) Frequently Asked Questions
1. What is Kilitch Drugs (India) Limited's Stock Symbol?
Kilitch Drugs (India) Limited trades on NSE under the ticker symbol "KILITCH".
2. What is Kilitch Drugs (India) Limited's stock price today?
One share of KILITCH stock can currently be purchased for approximately ₹342.55.
3. How can I contact Kilitch Drugs (India) Limited?
Kilitch Drugs (India) Limited's mailing address is 37/39, Ujagar Industrial Estate Waman Tukaram Patil Marg Deonar Mumbai 400088 India. The company can be reached via phone at 91 22 6121 4100.
4. What is Kilitch Drugs (India) Limited's official website?
The official website of Kilitch Drugs (India) Limited is https://www.kilitch.com.